Vadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).

Vadodara-based Sudeep Pharma files draft papers with SEBI for an IPO, aiming to raise funds through fresh issuance and offer ...

The IPO comprises a fresh issue worth Rs 95 crore and an offer for sale (OFS) of up to 1,00,76,492 equity shares by the ...

Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Total construction starts were up 13% in May to a seasonally adjusted annual rate of $1.16 trillion, according to Dodge ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Discover why Genmab A/S stands out as a high-margin biotech with strong partnerships, robust growth prospects, and ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...